These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10808252)

  • 21. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The discovery of immunostimulatory DNA sequence.
    Yamamoto S; Yamamoto T; Tokunaga T
    Springer Semin Immunopathol; 2000; 22(1-2):11-9. PubMed ID: 10944796
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent advances in immunostimulatory CpG oligonucleotides.
    Rothenfusser S; Tuma E; Wagner M; Endres S; Hartmann G
    Curr Opin Mol Ther; 2003 Apr; 5(2):98-106. PubMed ID: 12772497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells.
    Zhu FG; Marshall JS
    J Leukoc Biol; 2001 Feb; 69(2):253-62. PubMed ID: 11272276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis.
    Wedlock DN; Skinner MA; de Lisle GW; Vordermeier HM; Hewinson RG; Hecker R; van Drunen Littel-van den Hurk S; Babiuk LA; Buddle BM
    Vet Immunol Immunopathol; 2005 Jun; 106(1-2):53-63. PubMed ID: 15910992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-alpha, and NO production by bovine macrophages.
    Shoda LK; Kegerreis KA; Suarez CE; Mwangi W; Knowles DP; Brown WC
    J Leukoc Biol; 2001 Jul; 70(1):103-12. PubMed ID: 11435492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis.
    Logan KE; Chambers MA; Hewinson RG; Hogarth PJ
    Vaccine; 2005 Dec; 23(48-49):5526-32. PubMed ID: 16105710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptor signaling in anti-cancer immunity.
    Okamoto M; Sato M
    J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA.
    Simons FE; Shikishima Y; Van Nest G; Eiden JJ; HayGlass KT
    J Allergy Clin Immunol; 2004 Jun; 113(6):1144-51. PubMed ID: 15208597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes].
    Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI
    Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA vaccination using bacillus Calmette-Guerin-DNA as an adjuvant to enhance immune response to three kinds of swine diseases.
    Zhang S; Guo YJ; Sun SH; Wang KY; Wang KH; Zhang Y; Zhu WJ; Chen ZH; Jiang L
    Scand J Immunol; 2005 Oct; 62(4):371-7. PubMed ID: 16253124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased suppression of immune stimulatory CpG motifs in plant DNA.
    Wang Y; Zhou J; Liu B
    Immunol Lett; 2007 Dec; 114(2):73-80. PubMed ID: 17889375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hsp65 DNA vaccination carrying immunostimulatory DNA sequences (CpG motifs) against Mycobacterium leprae multiplication in mice.
    Nomaguchi H; Mukai T; Takeshita F; Matsuoka M; Maeda Y; Aye TM; Jahan N; Yogi Y; Endo M; Sato Y
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):182-90. PubMed ID: 12483966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Commemorative lecture of receiving Imamura Memorial Prize. II. Mode of action of oligonucleotide fraction extracted from Mycobacterium bovis BCG].
    Yamamoto S
    Kekkaku; 1994 Sep; 69(9):571-4. PubMed ID: 7526022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of NK cell (human and mouse) by immunostimulatory DNA sequence.
    Yamamoto S; Yamamoto T; Iho S; Tokunaga T
    Springer Semin Immunopathol; 2000; 22(1-2):35-43. PubMed ID: 10944798
    [No Abstract]   [Full Text] [Related]  

  • 38. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA vaccination against tumors.
    Prud'homme GJ
    J Gene Med; 2005 Jan; 7(1):3-17. PubMed ID: 15538731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections.
    Zimmermann S; Dalpke A; Heeg K
    Int J Med Microbiol; 2008 Jan; 298(1-2):39-44. PubMed ID: 17716944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.